DANIEL JOSÉ PIÑEIRO • Full Professor of Medicine, Universidad de Buenos Aires, Argentina • President-Elect, World Heart Federation • Advisor for HEARTS, Pan American Health Organization • Former President, Inter American Society of Cardiology and Argentine Society of Cardiology • Former Board of Trustees, American College of Cardiology World Heart Federation, • Former Board Member, World Heart Federation • Former Roadmaps Liaison Officer, Science Committee, World Heart Federation Prof. Daniel José Piñeiro currently is a Full Professor of Medicine at the Universidad de Buenos Aires, Argentina (2005-). He is very active in different international organizations: Trustee at the Board of Trustees of the American College of Cardiology (2018-2021), Advisor for HEARTS at the Pan American Health Organization (2018-), and Roadmaps Liaison Officer at the Science Committee of the World Heart Federation (2019-2020). Prof. Piñeiro has served twice as Member at the Board of the World Heart Federation (2011-2013 and 2017-2018), Member at Membership Committee of the American College of Cardiology (2016-2017), Chair of the Assembly of International Governors of the American College of Cardiology (2015-2017), President of the Inter American Society of Cardiology (2011-2013) and President of the Argentine Society of Cardiology (2005) He is a fellow of the American College of Cardiology, the European Society of Cardiology, and the American Heart Association. Prof. Piñeiro graduated as a physician with honors at the Universidad de Buenos Aires. He is involved in academic and educational activities as well as clinical practice. He also has a great interest in Public and Global Health as WHF Roadmaps and roundtables. He regularly presents his work at international and national conferences. He has publications including books, book chapters, and articles in international and national journals. Some of these articles are guidelines, consensus, white papers, and roadmaps devoted to Global Health. He deserved 8 national and international awards.
Jagat Narula, MD, PhD, MACC, FRCP is Philip J. and Harriet L. Goodhart Chair in Cardiology, Chief of Cardiology, St. Luke’s & Roosevelt Hospital of Mount Sinai, Professor of Medicine and Radiology, Icahn School of Medicine at Mount Sinai. He is also Associate Dean, Arnhold Institute for Global Health at Mount Sinai. He is the Editor-in-Chief of Journal of the American College of Cardiology: Imaging, Executive Editor of Journal of the American College of Cardiology and Editor-in-Chief of the Global Heart (the official Journal of World Heart Federation).
Dr. Narula after completing his cardiology fellowship training and PhD (Cardiovascular Immunology) from the All India Institute of Medical Sciences, Delhi, relocated to Massachusetts General Hospital (MGH) and Harvard Medical School in 1989. At MGH, after cardiology, heart failure & transplantation, and nuclear cardiology fellowships and he joined the cardiology faculty. In 1997, he moved to Hahnemann University School of Medicine, Philadelphia, where he was Thomas J. Vischer Professor of Medicine, Chief of the Division of Cardiology, Vice-Chairman of the department of Internal Medicine, and Director of Heart Failure & Transplantation Center. He subsequently joined University of California, Irvine School of Medicine (2003) as Chief of the Division of Cardiology, Associate Dean for Research, and Director of the Cardiovascular Center of the UC Irvine’s Douglas Hospital. He was also the Director of Memorial Heart & Vascular Institute, Long Beach Memorial Hospital, and Medical Director of the Edwards Lifesciences Center for Advanced Cardiovascular Technology in UC Irvine’s Henry Samueli School of Engineering. He moved to Mount Sinai as the Philip J. and Harriet L. Goodhart Chair in Cardiology, and the Director of Cardiovascular Imaging Program in the Mount Sinai’s Zena and Michael A. Wiener Cardiovascular Institute in 2011.
Dr. Narula has the unique distinction of being able to combine molecular and subcellular pathology and imaging with clinical imaging of the failing myocardium and high-risk coronary atherosclerotic plaques to develop novel strategies for prevention of cardiovascular disease and promotion of cardiovascular health in developed as well as developing countries. He has specifically contributed to two major areas including heart muscle cell apoptosis in heart failure, and lipid-rich atherosclerotic plaques that are susceptible to rupture and acute coronary events. He has brought novel experimental strategies to bedside and defined their applicability at the community level. He is currently actively involved in numerous population-based heart attack prevention programs including HAPPY [Heart Attack Prevention Program for You]. Based on his expertise in global medicine, he serves on the Advisory Council on Global Prevention of Cardiovascular Diseases of the Institute of Medicine of the National Academies of Sciences.
His research has been funded, in part, by the grants from National Institutes of Health. He is considered to be a true translationist and one of the infrequent investigators who has distinction of publishing in the best basic science and the best clinical journals including Science, Nature Medicine, PNAS, New England Journal of Medicine, Lancet, Circulation and JACC. With more than 1000 original research publications or presentations to his credit and more than 35 books or journal supplements edited, Dr. Narula has been awarded as ‘the best young investigator’ on several occasions for his research contributions. His mentoring prowess is exemplified by the fact that 20 of his fellows, working in his research laboratory, have been awarded young investigator awards. He was recently awarded as the Best Educator as also the Innovator in Cardiovascular Medicine by the American College of Cardiology in the year 2012, and was honored as the Master of the American College of Cardiology in March 2013. He has just received the Distinguished Scientist Award 2015 from the American College of Cardiology.
Prof. Pinto graduated at Lisbon University Medical School in 1984. He did his Cardiology internship at Santa Maria University Hospital – CHLN, E.P.E. (Lisbon, Portugal), and Stanford University Medical School (CA, USA), where he was a Clinical Fellow. He was then Clinical Attending in the Echocardiography laboratory and underwent an Interventional Cardiology Fellowship at the same institution.
He is currently Full Professor of Cardiology, Head of the Cardiology Department and of the Heart and Vascular Department of Santa Maria University Hospital, CHULN E.P.E., President of the World Heart Federation (WHF) (2021-2022). Recently he finished his term as the Dean of the Faculty of Medicine of the University of Lisbon (Lisbon, Portugal) (2015-2018)-(2018-2022).
National Coordinator of the Medical Schools Council (2018-2020) and President of the Executive Board of the Lisbon Academic Medical Centre (CAML) (2019-2021) and Director of Lisbon Cardiovascular Institute (ICVL) since 1999.
He was the President and founder of the European Association of Echocardiography (2002-04), a registered branch of the European Society of Cardiology (ESC), Chairman of the CPC (Congress Program Committee) of ESC (2008-10), Chair of the European Heart Agency(2016-2018) and ESC President (2014-16). He is currently the President of the World Heart Federation (WHF) (2021-2022), and integrates the Board of the European Heart for Children.
He is a Fellow of the European Society of Cardiology (FESC), American College of Cardiology (FACC), American Society of Angiology (FASA), Society for Cardiac Angiography and Interventions (FSCAI) and the American Society of Echocardiography (FASE) and Honorary Member of several international societies, including Societé Française de Cardiologie, Sociedad Colombiana de Cardiologia, American Society of Echocardiography, Societá Italiana de Ecografia Cardiovascular, Hungarian Society of Cardiology, Japanese Circulation Society, Sociedad Peruana de Cardiologia, Romanian Academy of Medical Sciences, Romanian Society of Cardiology, Russian Society of Cardiology, and Slovakian Society of Cardiology. Appointed by acclamation (29 November 2018) as Honorary Member of the National Academy of Medicine of Brazil. He is the Honorary President of the International Committee for Education and Cooperation of the Italian Society of Medical Science (SISMED). Honorary Member of the Brazilian Society of Cardiology(Nov 2020) and Dante Pazzanese Medal(Nov. 2020).
He was the Editor in Chief of the Portuguese Journal of Cardiology (1999-2015), and is currently Consulting Editor and Member of the Advisory and Editorial of Board of several international peer-reviewed journals, and Expert Reviewer for the European Commission. Prof. Pinto has published over 600 indexed articles and has presented over 1500 lectures/chairmanships at national and mostly international meetings.
John Kelly has broad experience in clinical, management and leadership roles across the health sector. John was the Group CEO of the National Heart Foundation of Australia 2016-2021 and is currently the CEO of the Australian Nursing and Midwifery Accreditation Council. John commenced his health career as a cardiothoracic nurse specialist. After graduating in Organisational Psychology and Law, John worked in various health organisations, non-profit entities and the law. John was a health law partner for 15 years at leading top 10 legal practices in Australia.
Immediately prior to his role at the Heart Foundation, John served for four years as CEO of Aged & Community Services Australia, which represented the church and charitable sector in the $9b retirement living and aged care sector.
John has extensive experience on non-profit boards, including time as Chair of large Australian charities, The Smith Family as well as the Royal College of Nursing Australia and Uniting Care Ageing (NSW & ACT). His international experience includes representing Australia on the International Council of Nurses.
John holds academic appointments with the Sydney Nursing School at University of Sydney and the Faculty of Health at the University of Technology, Sydney (UTS).
In 2009 John was named a Member of the Order of Australia (AM) and received the Alumni Award for Excellence from UTS. In 2010 John was appointed by the Federal Government as Commonwealth Aged Care Commissioner. In 2019 John was awarded a Distinguished Life Fellow with the Australian College of Nursing.
Dr. Mbakwem is a professor of Medicine at the University of Lagos and a consultant cardiologist to the Lagos University Teaching Hospital. She completed her residency training in internal medicine and cardiology at the Lagos University Teaching Hospital and received a Fellowship of the West African College of Physicians. She underwent further training in cardiology at the Wolfson Heart Institute in Tel Aviv, Israel and Azienda Sanitaria, Tuscany, Italy. Dr Mbakwem’s research interest includes Heart failure, systemic and pulmonary hypertension, heart disease in women, effective communication in disease management and the psychosocial issues in cardiovascular diseases. She is a member of the Nigerian Hypertension society guidelines writing committee. She is the immediate past President of the Nigerian Cardiac Society and a member of the European Society of Cardiology working group on Peripartum cardiomyopathy. She is the treasurer of PASCAR
Richard A. Chazal, MD, MACC
Rick Chazal is a senior cardiologist and the Medical Director of the Heart and Vascular Institute for Lee Health, a four hospital, not-for-profit system in Fort Myers, Florida. Dr. Chazal is the Past President of the American College of Cardiology. He has practiced clinical cardiology in Fort Myers since 1983 with expertise in echocardiography, diagnostic catheterization and coronary computerized tomography angiography. During his tenure, he has been a participant in multiple clinical trials.
Chazal received his undergraduate degree from the University of Florida and went on to complete medical school and Internal Medicine training at the University of South Florida. Subsequently, Chazal completed a fellowship in Cardiovascular Disease at the Krannert Institute of Cardiology at Indiana University, where he spent one year working under Harvey Feigenbaum, MD, FACC as a designated echocardiography fellow.
Chazal served as councillor, treasurer and president of the ACC’s Florida Chapter. Subsequent to his stint as president and governor for the Florida Chapter, he was elected Chair of the ACC Board of Governors. He has also been ACC Treasurer and Chair of the Budget and Finance Committee. In combined capacities, Chazal has spent thirteen years on the ACC Board of Trustees. Nationally, Chazal has served as a member and/or chair of over 50 committees and workgroups for the College.
He is a member of Alpha Omega Alpha and Omicron Delta Kappa honoraries through the University of South Florida. He is the recipient of multiple awards from the ACC Florida Chapter, including the Special Achievement Award, the Presidential Citation, the Distinguished Service Award, and the Founder’s Award. In 2011, the Southwest Florida Affiliate of the American Heart Association awarded him their Golden Heart Award, and in 2014 he was designated Distinguished Fellow of the American College of Cardiology. He received the inaugural Community Teaching Award from the Family Medicine Residency Program via Florida State University School of Medicine Fort Myers Program in 2015. The Lee County Medical Society honored Chazal with the Lifetime Achievement Award in 2017. He serves as courtesy assistant professor of medicine for the University of Florida and clinical associate professor of medicine for Florida State University.
He and his wife Linda have three children and three grandchildren.
Dr Juwairia is a consultant non invasive cardiologist in Rashid hospital. She is an active
member of Emirates Cardiac Society and is the current president. She is the first women to hold this title in the Arabian gulf countries. She has been part of the scientific committee for Emirates Cardiac Society annular meeting for the past 5 years. She has both organized and participated in multiple educational activities, webinar and workshops over the years and has a great passion for teaching. She is also in charge of the heart failure clinic in Rashid hospital and has been on multiple advisory boards for heart failure therapy. She is currently the program director of Saudi board cardiology fellowship program in Rashid Hospital. She has developed the educational curriculum and organized the academic teaching in Rashid hospital cardiology department. She is also a faculty member of the Saudi board of internal medicine at Rashid hospital. She is in charge of the outpatient improvement program for the cardiovascular service line in Dubai health authority.
Dr Juwairia is the first woman to hold the role of president of Emirates Cardiac Society from starting from 2022 until present. She is the Co-chair of the scientific committee of emirates cardiac society meeting annular meetings in collaboration with the American college of cardiology. She liaisons with international societies and oversees educational activities organized by the society.
Before Dr Juwairia was a board member and the vice president of the society EMIRATES CARDIAC SOCIETY from 2019 to 2021. She represented the society in conferences and meetings.
From 2016 to 2018 she was a Chairperson Of Emirates Cardiac Imaging Group, organized educational activities and workshops under the umbrella of Emirates Cardiac Society.
From 2015 until present Dr Juwairia is a Consultant Cardiologist, an expert in diagnosing and managing multiple cardiac problems including coronary artery disease, valvular heart disease, cardiac arrhythmia, and heart failure. She manages cardiovascular risk factors like hypertension, dyslipidemia, diabetes and obesity.
She manages the echocardiography laboratory and reviews studies performed by cardiac technicians or cardiology fellows. She performs transesophageal echocardiograms and intraprocedural echocardiograms and teaches junior cardiologists and cardiology fellows how to perform them. She is in charge of the outpatient improvement program in Dubai health authority. She is a member of the structural heart team in Dubai health authority.
ADULT ADVANCED ECHOCARDIOGRAPHY FELLOWSHIP, MCGILL UNIVERSITY,
MONTREAL, CANADA – 2014-2015
CARDIOLOGY FELLOWSHIP, MCGILL UNIVERSITY, MONTREAL, CANADA – 2011-2014
INTERNAL MEDICINE RESIDENT, MCGILL UNIVERSITY, MONTREAL, CANADA – 2008-2011
INTERNAL MEDICINE RESIDENT, DUBAI HEALTH AUTHORITY, 2005-2008
INTERNSHIP, DUBAI HEALTH AUTHORITY, 2004-2005
José Ramón González Juanatey MD PhD, Professor of Cardiology at the University ofSantiago de Compostela (since 2000), Head of Cardiology and Coronary Care Unit of theUniversity Hospital of Santiago de Compostela (since 2007) and past President of the SpanishSociety of Cardiology (2013-2015). José Ramón González Juanatey MD PhD is author of morethan 740 research articles (38000 times cited / H-index: 59, source WoS), published in the bestgeneralist (NEJM, Lancet, etc.) and cardiovascular journals (Eur. Heart J., JACC, Circulation,Int J Cardiol, Cardiovascular Research, Eur. J. Heart Fail., Revista Esp. Cardiol., etc.). José Ramón González Juanatey is the coordinator of the Inflammation Area and principalinvestigator of the Cardiology Group at the Health Research Institute of Santiago deCompostela (IDIS). He was recognized as Spanish Doctor of the Year in 2014, member ofthe Board of Directors of the Spanish Network on Cardiac Insufficiency (REDINSCOR), formerpresident of the Hypertension Chapter of the Spanish Cardiology Society, governor for Spainof the International Society of Cardiovascular Pharmacology and President of ACC SpanishChapter.Dr. González Juanatey is the leader of the cardioCHUS research group of the UniversityHospital of Santiago de Compostela (CHUS), integrated in the Health Research Instituteof Santiago de Compostela (IDIS), the Center for Research in Molecular Medicine andChronic Diseases of the USC (CIMUS) and also in Center of Biomedical Research in Netfor Cardiovascular Diseases (CIBERCV) of the Institute of Health Carlos III (ISCIII) of Spain.The intense work of the group is reflected by the number of research projects obtained inpublic calls during the last 10 years at regional (6), national (more than 20) and internationallevel (5) projects from the European Commission: 3 of them are clinical: TIMELY, EUCAREand SECURE, another pre-clinical: FABIMED project, and the last is in the manufacturingand clinical interface (ATLANTIC-KET-MED). Financial support has also been achieved fromprivate foundations (Mutua Madrileña, Spanish Society of Cardiology…) and pharmaceuticalcompanies (Novartis, Bayer, Daiichi-Sankyo, AstraZeneca…). More recently, our group wasawarded with the first “intramural project” from CIBERCV, an evidence of our capacity ofleadership.The main lines of investigation are: heart failure, with special emphasis on heart failurewith preserved systolic function, hypertension, atrial fibrillation, cardiac rehabilitation,hemodynamics, cardiomyocyte endocrinology, epicardial adipose and endothelial tissuebiology, and chemotherapy-induced cardiotoxicity. The Cardiology Department of CHUS hasbeen repeatedly chosen for participation in numerous clinical trials (up to 70 different clinicaltrial per year in the last times). In recent years, the Cardiology Department has been awarded with the Best in Class (BIC)award (editions of 2013, 2014, 2015, 2017, 2018, 2019 and 2020), Best in Class Excellenceaward (2020), Innovation in Health award by TelecardioCHUS program and the ReCo program(cardiac rehabilitation in cancer patients).
Professor D. Prabhakaran is a cardiologist and epidemiologist by training. He is an internationally renowned researcher and is currently the Vice President- Research & Policy, Public Health Foundation of India, Executive Director of Centre for Chronic Disease Control, New Delhi, India and Professor (Epidemiology) London School of Hygiene and Tropical Medicine, UK. He heads the Centre for Control of Chronic Conditions at PHFI which is a joint initiative of four leading institutions (Public Health Foundation of India, London School of Hygiene and Tropical Medicine, All India Institute of Medical Sciences, New Delhi and Emory University). This centre conducts cutting edge research in the prevention of chronic diseases in India and the developing world.
His work spans from mechanistic research to understand the causes for increased propensity of cardiovascular diseases (CVD) among Indians, to developing solutions for CVD through translational research and human resource development. Prof. Prabhakaran is a Fellow of the Royal College of Physicians, UK, Fellow of the National Academy of Sciences, India, and an Adjunct Professor at the Emory University. He is member of Executive Council of the International Society of Hypertension (ISH) and Chair of the International Society of CVD Epidemiology and Prevention (ISCEP). He has received funding from NHLBI, Wellcome Trust, European Commission and several other international and national funding bodies. He has mentored over 50 post-doctoral and doctoral students so far. He has authored several chapters and over 500 scholarly papers with an H index of 97. Listed as the topmost researcher in Medicine in India terms of publications for the years 2009-2014 by Scopus and Department of Science & Technology, Government of India. He is the lead editor of the Cardiovascular Disease Volume of the latest Disease Control Priorities Project. He is the lead editor of Tandon’s text book of Cardiology a two volume comprehensive book on Cardiology for Indian Cardiologists and Fellows.
General Secretary, Swedish Heart Lung Foundation, 20141001 – ongoing
Assistant Secretary General, Heart-Lung Foundation, 2012 – 2014
Support the GS in business development. Creating commitment and consensus on business and brand and communications platform internally and externally. Ensure that Board decisions are implemented by operational lead efforts to develop and implement the overall strategy and plans for the business. Ensure revenue targets.
Fundraising and Marketing Manager, The Swedish Heart-Lung Foundation, Stockholm, October 2004 – 2014
Overall responsible for the strategy which aims to develop the business total revenue (collection), marketing and brand awareness.
Results for the first 8 years is a revenue increase from 70 million to about 234 million / per year (see picture below). A revenue increase of about 20 percent per year. The main tasks are to take responsibility for the brand, marketing and communication, advertising and marketing initiatives, product ie all revenue channels and loyalty strengthening efforts sensors (clients). Responsible for revenue and cost budget. Dense relationship with agencies, partners, suppliers, directors, researchers and European colleagues. Personnel included in the service of about 20 people and two group leaders. Member of the management.
Fundraising Manager, The Swedish Heart-Lung Foundation, Stockholm, August 1999 – October 2004
Developed a basis for the existing collection and marketing efforts. Implemented methods DR, TM and requirements posed new computer system for the collection business. Responsible for the customer – and exhibition activities.
Budgetary and supervisory responsibility for about four people. Contact with clients and advertising agencies, printers, agents, agencies Etc.
Project manager and coordinators, The Swedish Heart-Lung Foundation, Stockholm,
August 1996 – August 1999. Start-up and establishment of a new international health project in Sweden; Health Path. In cooperation with the municipalities establish specific walking trails to the public in order to increase the daily exercise for everyone. Today there are about 80 loops.
Coordinator of the exhibition activities and events and to the Fund volunteering.
District Manager Janne Class AB, Stockholm, Sales Manager for Mälardalen. November 1995 – July 1996. Sales of all products to opticians and its workshops excl frames and lenses. Travel service with client meetings and largely phone contact.
District Manager, IMMOBILIZER AB, Stockholm, August 1995 – November 1995. Responsible seller immobilizer system for motor vehicles to dealers and workshops.
Sales through its own pre-booked meetings with customers.
Teachers, Spånga Gymnasium, Stockholm, September 1992 to June 1995 Fittjaskolan, Stockholm, January 1989 – June 1991 and January 1987 – June 1987 Resource Teachers in Swedish, electrical / telecommunications engineering, English and mathematics for grades 7-9 and high school students ride first
Communicative, curious, driven and innovative.
Lindberg & Göthberg, Executive senior program, 2015 – 2017
Stockholm School of Economics IFL Executive, 2012- 2013
LPU, leadership through personal development
Executive MBA from Stockholm University School of Business at the Department of Business Administration, Executive MBA 2 years
EMBA Stockholm, 2010 – 2012
– Financial Statisment Analysis
– Strategy in Practice and Marketing Management –
Corporate Social Responsibility
– Change management
– Global Cross Cultural Business Behavior
– Ethical leadership
– Corporate Governance
– Essay – Does the SFC-code support donor’s interest?
IHM MASTER 1.5 years 2005-2007
DIHM, Operations Management
DIHM, Business Development
DIHM, Personal Leadership
DIHM, Business Communication, 2 years 2001-2003
– Business Acumen, Module 1
– Business of Communication grounds, Module 2
– Communication management and change instruments, Module 3
– The company’s reputational capital, Module 4
– Communication with the market, Module 5
– Shareholders thesis, Module 6
3-year technical school Brännkyrka and Åsö School, 1984-88
Swedish Pharmaceutical Society, board member 2018- ongoing
Research Sweden, board member 2015 – ongoing
King Oscar the II jubilee foundation, board member 2014- ongoing
The Swedish Fundraising Council (SFC), board member 2012-2018
The Swedish Fundraising Council European certification training (EFA) for fundraisers at Berghs School of Communications, 2009 – ongoing
The Swedish Fundraising Council Volunteer Fundraising., Course Leader for FRII’s annual course in collection, 2007- 2014
Swedish Fundraisers; board member 2004 – in 2008. Non-profit association for the industry fundraisers (collector) with a mandate to pursue knowledge between different fundarisers.
Engaged as a lecturer at the example:
– Bonnierförlagen AB
– European Heart Network,
– DR Academy
– Berghs School of Communication
– SFC seminar, NGO Fundraising
Swedish – Native. Fluent spoken and written
English – Good command of spoken and written.
Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis Medical Center, Sacramento with Dr John Laird to complete his peripheral vascular interventional program. He is doubly accredited for cardiology and intensive care medicine in Singapore. He is the head of cardiology at the National Heart Centre Singapore. He is a practising interventional cardiologist and holds associate professor appointments at Duke NUS and lecturer appointments at the Yong Loo Lin and Lee Kong Chian School of Medicine. In 2013, he was in the Dean’s list for his cohort at the Singapore Management University for his executive MBA.
Dr Jack Tan successfully organized the ASEAN Federation of Cardiology Congress 2012 as the scientific chairman and was the organizing chairman for the APSC (Asian Pacific Society of Cardiology) meeting 2017 together with the WHF summit in Singapore. Currently he is an executive board member at Singapore Heart Foundation, APSIC (Asian Pacific Society of Interventional Cardiology) and ISCP(International Society of Cardiovascular Pharmacotherapy) . He is the past president of SCS (Singapore Cardiac Society) and past board member (Continental chair) of WHF (World Heart Federation). He is the immediate past president of APSC and ISCP. In 2020, he was awarded the Public Administration Medal (Bronze) Pingat Pentadbiran Awam PPA(G) during Singapore’s National Day from the Prime Minister’s Office, followed by the Long Service Medal (Pingat Bakti Setia, PBS) in 2021.
Liesl Zühlke, MBChB DCH FCPaeds Cert Card MPH FESC FACC PhD trained as a Paediatric Cardiologist in Cape Town and Dusseldorf, Germany. She has a MPH in clinical research methods, and her doctorate at the University of Cape Town provided new insights on outcomes of symptomatic and asymptomatic Rheumatic Heart Disease.
Prof Zuhlke is widely regarded as an emerging leader in cardiovascular medicine on the African continent. Her major research interests lie in Rheumatic Heart Disease and congenital heart disease. A paediatric cardiologist in the Dept of Pediatric Cardiology at RXH, she worked as the clinical co-coordinator of the ASAP programme, managing several large scale RHD projects in South Africa and on the African continent. In this capacity, she was instrumental in the development, coordination and management of the largest prospective RHD registry the Rheumatic Heart Disease Registry (the REMEDY study) involving 25 sites, in 12 African countries, Yemen and India and is currently the national leader of the INVICTUS study, which aims to enrol over 30 000 RHD patients.
She has received a number of awards including an academic excellence award from Discovery, NIH Fogarty Fellowship, Wellcome CIDRI and Thrasher awards and the Hamilton Naki Post-doctoral Clinical Scholarship, an award given to clinical scholars of excellence. She is the immediate past president of the pediatric cardiac society of South Africa, President of the South African Heart Association and the chairperson of the Pan African Society of Cardiology Paediatric Cardiology and Cardiac Surgery Task force. She was one of the organizers of the 6th World Congress of Paediatric Cardiology and Cardiac Surgery 2013, the World Congress of Cardiology and Cardiovascular Health 2016 and is on the organising committee for the World Congress of Paediatric Cardiology and Cardiac Surgery in 2017. A previous board member of the Heart and Stroke Foundation of South Africa, she is now on the board of the Hatter Institute for Cardiovascular Research and is co-director of Rheach (Rheumatic Heart Disease-Evidence, Advocacy, Communication and Hope), the recipient of one of the largest grants from Medtronic Philanthropy for work in Rheumatic heart disease. The initiative will be providing scientific and technical support for Global RHD programmes over the next five years.
Prof. Dr. med. Stephan Achenbach graduated from Medical School at Friedrich-Alexander University Erlangen-Nürnberg, Germany in 1993 and subsequently completed his training in Internal Medicine and Cardiology at the associated university hospital. In 2002/2003, he was a research fellow at the Department of Radiology and Cardiology Division, Massachusetts General Hospital. Since 2012, he is the Chairman of the Department of Cardiology and Professor of Medicine at the University of Erlangen, Germany. His main clinical interests are interventional cardiology, general cardiology as well as cardiac imaging. His research is focused on cardiac interventions and cardiac imaging with a special focus on computed tomography of the heart and the use of imaging to support coronary and structural interventional procedures.
Stephan Achenbach was the Founding President of the Society of Cardiovascular Computed Tomography. He has been Editor-in-Chief of the Journal of Cardiovascular Computed Tomography. He is the President of the European Society of Cardiology (ESC) for the mandate 2020 to 2022. Academic awards include the Jan Brod Award for Clinical Research of the Medical School of Hannover, Germany (1999), the Thomas C. Cesario Distinguished Visiting Professorship Award, University of California Irvine School of Medicine (2007), the Simon Dack Award, American College of Cardiology (2009), the Gold Medal of the Society of Cardiovascular Computed Tomography (2015), the Sir Godfrey Hounsfield Award of the British Institute of Radiology (2016), the Pioneer Award in Cardiovascular Computed Tomography, Society for Cardiovascular Computed Tomography (2019) and the Fritz Acker Award, German Society of Cardiology (2020). In 2017, he was selected by AuntMinnie.com as the “Most Influential Radiology Researcher” and he has repeatedly received the 1st Prize Best Teaching Award, Clinical Medicine, Medical Faculty of the University of Erlangen-Nürnberg (2013, 2014, 2016, 2017, 2018, 2019, 2020, 2021).
Professor Junbo Ge is academician of Chinese Academy of Sciences; the chief of cardiology department of Zhongshan Hospital, Fudan University; the chief of Shanghai Cardiovascular Clinical Center; the chairman of Shanghai Institute of Cardiovascular Diseases; the head of Institutes of Biomedical Sciences;the head of Institute for Pan vascular Medical Research, Fudan University;the chairman of Pan vascular Fund, Fudan University; director of Engineering Research Center for Cardiovascular Devices, Ministry of Education; He was awarded Scholars of the Yangtse River; Elite of science and technology; National Labor Medal; Tan Jiazhen prize in life sciences; the national “Bethune” Medal, etc. He is also the president of the Chinese Society of Cardiology; the chairman of China Cardiovascular Association; board member of The Society for Cardiovascular Angiography and Interventions; member of the international advisory board of American College of Cardiology. Prof. Ge dedicates to the optimization and innovation of diagnosis and treatment strategy for coronary artery disease and made extraordinary achievements in intravascular ultrasound (IVUS). His research areas also includes development of novel coronary stents, treatment strategy optimization of complex CAD and stem cell therapy. Prof. Ge has been responsible for over 20 scientific research projects supported by the government, Furthermore, a total of over 300 papers published by Prof. Ge have been included by SCI-E (as the first author or the corresponding author). Prof. Ge has edited 20books (one published abroad) and co-edited more than 20 monographs and textbooks. He is the chief editor of Internal Medicine (8th edition), Practice of Internal Medicine (15th edition), Cardiology Plus and deputy editor of Herz. As the first person to complete a project, Prof. Ge has received more than fourteen awards, including the second prize of National Award for Science and Technology Progress, the second prize of National Award for Technological Invention, the first prize of Science and Technology Progress Award presented by the Ministry of Education, the second prize of the China Medical Technology Award(twice),the first prize of the Shanghai Science and Technology Progress Award, etc.
Dr. Akasaka graduated from Wakayama Medical University in 1982 and finished his residency at Kobe City Medical Center General Hospital (KCGH).
He had been clinical fellow at Harefield Hospital in United Kingdom in 1987.
From 1989, he had done clinical research work in the field of coronary physiology using coronary flow velocity and pressure extensively at KCGH as a director of cardiac catheterization laboratory for 8 years.
After he moved to Kawasaki Medical University as associate professor, he started OCT for 5 years.
And then, he became Professor of Wakayama Medical University in 2005 and he has been devoted to the clinical research work using OCT and coronary physiology.
He has published the many papers regarding coronary imaging using OCT in addition to coronary physiology research. Based on his clinical and research work, he has been the executive board members in various cardiology societies and the course co-directors of several coronary live-demonstration courses in the world.
Thomas A. Gaziano M.D., M.Sc. is an Associate Professor of Medicine at Harvard Medical School in the Division of Cardiovascular Medicine at Brigham and Women’s Hospital (BWH). He is Director of Global Health and Economic Evaluations within Cardiovascular Innovations at BWH where he evaluates prevention programs in clinical services. He is currently a principal or co-principal investigator on three NIH-funded grants in Argentina and South Africa, the main focus of which are the implementation of effective cardiovascular therapies or policies in low-income settings. His Harvard CVD PREDICT model is used to evaluate health outcomes, financial impacts, and the cost-effectiveness of CVD intervention strategies. He serves on the Board of the World Heart Federation.
Dr. Griffiths is the Chief Executive of the British Heart Foundation (BHF). She re-joined the BHF as its Chief Executive from the Institute of Cancer Research (ICR) where she had a range of strategic and operational responsibilities; most recently as Chief Operating Officer.
Charmaine did her PhD and postdoctoral research in Neuroscience at University College London, alongside working in public engagement for the Wellcome Trust. Her subsequent career at the BHF included roles spanning communications, policy and assurance, as well as strategy.
Her non-executive experience includes roles at the Human Tissue Authority, the Royal Marsden NHS Foundation Trust, Brain Research UK and the Cranfield Trust.
Charmaine led the development of our previous organisational strategy, winning the Best Strategic Transformation category at the Chief Strategy Officer Awards 2014.
DIANA DANIELA VACA MCGHIE is a seasoned executive with over two decades of non-profit sector experience. Passionate for addressing a myriad of health issues. Impeccable track record in bringing diverse voices into the public policy discourse including clinical professionals and patients. Experienced in addressing health equity and program development to drive impact. Intuitive thinker with competitive global business intelligence and exceptional communicator. Strong interpersonal skills that create impactful partnerships geared for expansion and growth. Servant leader that inspires and motivates strong performance among diverse teams.
Diana is currently a Director, Global Advocacy, American Heart Association, Washington D.C. She leads the global advocacy portfolio across the organization. Primary spokesperson for communicating organization’s science and policy positions within global forums. Cultivate and manage relationships with partners and key decisionmakers in the public and private sector. Manage volunteer and staff leadership in support of global programming. Identify allies and partners to advance mission and secure funding for the execution of new advocacy initiatives. Secured organization’s accreditation to the United Nation’s Economic and Social Council and special consultative status to the World Health Organization. Executed global programming that defined global stroke and cardiovascular advocacy priorities. Closed over $1 Million dollars of new revenue for advocacy programming. Executed high level ministerial meetings that lead to market access for evidence-based programming and policy adoption. Served as chair for two D.C. based global coalitions securing the inclusion of report language to U.S. global funding at the U.S. Agency for International Development.
Diana served as a Director, Fellowships & Stakeholder Relations, American Cancer Society, Washington D.C. from May 2003 to October 2009 where she developed partnerships with organization’s affiliates to support the execution of a capacity building program focused on nascent cancer societies globally. Actively engaged with regional boards and staff leadership to secure financial support to fund fellowship program. Led a matrix team and interns to facilitate the administrative processes related to grants and development of progress reports. Provided expert advise and technical assistance in key functional areas important for mission impact.
Before that Diana worked as Manager, Human Resources Development, American Cancer Society, Atlanta, GA from April 2001 to April 2003 where she developed and implemented a national diversity training and education initiative across staff and volunteers. Lead trainer and content expert on cultural awareness and sensitivity curriculum. Provided guidance, consultation, and field support on diversity and organizational development issues, specifically the development of diversity plans and key performance metrics. Assessed organizational issues relative to diversity and its impact on organization’s programs and services. Designed solutions to organizational issues relative to diversity and their potential impact on programs and services.
Professor of Clinical Epidemiology, University Medical Center Utrecht
Rick Grobbee, is founder of the Julius Center for Health Sciences and Primary Care (1996), a division of the University Medical Center Utrecht (UMCU) currently employing approximately 500 staff, and of Julius Clinical (2008), a full service Academic Clinical Research Organization. He currently acts as the chair of the Center for Circulatory Health at the UMCU governing cardiovascular patient care, research and education. Previous positions include Professor of Clinical Epidemiology at Erasmus University Rotterdam, member of the board of Erasmus University Medical Center, and visiting Associate Professor at Harvard University, Boston. He holds honorary appointments in Sydney and Kuala Lumpur. He has been a (principal) investigator in many large-scale epidemiologic studies and randomized intervention trials relating to the prevention and treatment of cardiovascular, cardiometabolic, and cardiorenal disease. In addition he works on the principles and methods of treatment research, trial design and data analysis. He is listed in the top 100 global most influential biomedical researchers (Eur J Clin Invest 2013 Dec;43(12):1339-65) and has consistently been ranked as highly cited author by Web of Science over the last decades. Rick Grobbee has been on the editorial boards of several journals and (inter) national scientific, search, and site-visit committees. Current journal roles include senior consulting editor of the European Journal of Preventive Cardiology of which he served as editor-in-chief for eight years. He is past-president of the European Association for Preventive Cardiology and member of the board of the European Society of Cardiology. In 2010 he was appointed Distinguished University Professor of International Health Sciences and Global Health at Utrecht University. Rick Grobbee is fellow of the Royal Dutch Academy of Sciences and served as the chair of its Medical Section and Advisory Council for the Medical Sciences. He is honorary fellow of the Indonesian Heart Association and of the Romanian Society of Cardiology. In recent years his attention has increasingly been directed towards global circulatory health. In 2017 he was knighted by the Dutch King (Knight in the Order of the Dutch Lion). To date, Prof. Grobbee has authored or co-authored over 1,300 scientific papers (PubMed), chapters, and books, and has supervised more than 140 PhD fellows. His Hirsch index (Web of Science) is 146.
Dr. Sosa Liprandi is the Head of Cardiology, Sanatorio Güemes. Buenos Aires, Argentina. Associated Director, Austral Cardiovascular Institute. Ushuaia, Tierra del Fuego. Argentina Director. Idea Medica. Research & Education. Buenos Aires, Argentina Director. Post graduated Medical School in Cardiology. Universidad de Buenos Aires.
President Inter-American Society of Cardiology Former President of the Argentine Society of Cardiology Former Vice-President of the Argentine Heart Foundation
Fellow American College of Cardiology Fellow Inter-American society of Cardiology Full Member. American Society of Nuclear Cardiology. Full Member. International Society of cardiovascular Pharmacotherapy.
Jean-Luc Eiselé has worked in the field of medical association management for almost 20 years. He was trained as a biochemist working at the Biozentrum in Basel and the Pasteur Institute in Paris. In 1999, he joined the European Respiratory Society as Scientific Affairs Manager in charge of the Annual Congress and was offered to develop the educational activities, in particular the online portfolio. In 2001 he was nominated Deputy Executive Director and in 2007 ERS Executive Director. In 2011, he was appointed by FDI World Dental Federation as Executive Director, developing in particular its advocacy work and launching successfully the World Oral Health Day. He joined the World Heart Federation (WHF) as Chief Executive Officer in May 2017, strengthening the business model, the focus on communication and advocacy and membership engagement.
|cookielawinfo-checbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|